Leuplinection and condition aggravated Patient Reports February 09, 2010

Leuplinection Side Effects Report #4990859-1
Leuplinection side effect was reported by a Consumer or non-health professional from JAPAN on Apr 20, 2006. Male patient, 74 years of age, was diagnosed with prostate cancer  and was treated with Leuplinection. After drug was administered, patient experienced the following side effects: condition aggravated, hepatitis c , malaise. Leuplinection dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CHLORMADINONE ACETATE. Patient recovered.

Leuplinection Side Effects Report #5391804-X
Leuplinection side effect was reported by a Physician from JAPAN on July 12, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer  and was treated with Leuplinection. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, blood creatine phosphokinase increased, condition aggravated, interstitial lung disease, polymyositis, pulmonary alveolar haemorrhage, pulmonary mycosis. Leuplinection dosage: 3.75 MG (3.75 MG, 1 IN 28 D); SUBCUTANEOUS. During the same period patient was treated with CASODEX, TAMSULOSIN, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died.